Modern’s new vaccine results have provided an amazing boost for the stock market. Moderna announced that its phase three vaccine trial has produced a 95% efficacy rate.

The stock market shot up over 500 points as a result of the news. This continues a set of interesting trends that will define stock market performance for the rest of the year.

source